Literature DB >> 19748874

Telepharmacy services in an urban community health clinic system.

Annie Y Lam1, Dave Rose.   

Abstract

OBJECTIVE: To describe telepharmacy-related services and outcome.
SETTING: Suburban western Washington State during 2007 to 2008. PRACTICE DESCRIPTION: Five network clinics without in-house pharmacies are remotely connected to a central pharmacy to provide telepharmacy services. PRACTICE INNOVATION: Automated drug dispensing system (ADDS) units, webcams, and electronic medical charts were used to provide remote medication order processing/dispensing, patient counseling, refill authorizations, and medication assistance referral services. MAIN OUTCOME MEASURES: Patient demographics; numbers of dispensed medications, patient consultations, refill authorizations, and service referrals; pharmacist feedback; and workflow changes.
RESULTS: At five network sites, 12,000 patients received 3,282 new prescriptions per month with webcam-enabled consultations, 589 monthly refill prescriptions, 2,800 pharmacist-provided refill authorizations, and 250 medication assistance referrals. Antibiotics were the most frequently dispensed medications. Pharmacists commented that webcam-enabled interviews provided better privacy and longer counseling duration. Six new staff members (one pharmacist and five pharmacy technicians) were added. Workspace and staff responsibilities were reassigned to facilitate medication prepackaging and ADDS prescription processing.
CONCLUSION: Expanded application of telepharmacy technology can improve patient access to pharmaceutical care beyond remote medication dispensing to include point-of-care refill authorization and medication assistance referrals. Further research to explore patient-focused services and to assess economic, humanistic, and clinical outcomes of telepharmacy services is needed.

Entities:  

Mesh:

Year:  2009        PMID: 19748874     DOI: 10.1331/JAPhA.2009.08128

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  7 in total

1.  Report of the 2013-2014 Professional Affairs Standing Committee: advancing the pharmacy profession together through pharmacy technician and pharmacy education partnerships.

Authors:  Miriam A Mobley Smith; Cynthia J Boyle; Jan M Keresztes; Janet Liles; Linda Garrelts MacLean; Everett B McAllister; Janet Silvester; Nancy T Williams; Lynette R Bradley-Baker
Journal:  Am J Pharm Educ       Date:  2014-12-15       Impact factor: 2.047

2.  Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19.

Authors:  Suhaib M Muflih; Sayer Al-Azzam; Sawsan Abuhammad; Sara K Jaradat; Reema Karasneh; Mohammad S Shawaqfeh
Journal:  Int J Clin Pract       Date:  2021-04-21       Impact factor: 3.149

3.  A scenario-planning approach to human resources for health: the case of community pharmacists in Portugal.

Authors:  João Gregório; Afonso Cavaco; Luís Velez Lapão
Journal:  Hum Resour Health       Date:  2014-10-13

Review 4.  Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges.

Authors:  Arjun Poudel; Lisa M Nissen
Journal:  Integr Pharm Res Pract       Date:  2016-10-26

5.  Public Perceptions About Home Delivery of Medication Service and Factors Associated with the Utilization of This Service.

Authors:  Rana Abu-Farha; Karem H Alzoubi; Mai Rizik; Samar Karout; Rania Itani; Tareq Mukattash; Eman Alefishat
Journal:  Patient Prefer Adherence       Date:  2022-08-22       Impact factor: 2.314

6.  Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic.

Authors:  Erik Hefti; Benjamin Wei; Kristen Engelen
Journal:  Telemed J E Health       Date:  2022-01-11       Impact factor: 5.033

7.  Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: A focus group.

Authors:  Eman Alhmoud; Dania Al Khiyami; Raja Barazi; Mohammed Saad; Ali Al-Omari; Ahmed Awaisu; Rasha El Enany; Moza Al Hail
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.